장뇌삼 잎 추출물의 분획물이 Scopolamine으로 유도된 Mouse의 기억력 개선에 미치는 영향
Effects of Korean Mountain Ginseng Leaves and Its Active Constituents on Scopolamine-induced Amnesia in Mouse
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study was to characterize the effect of the fraction of Korean mountain ginseng folium (FKG) on the learning and memory impairments induced by scopolamine. Methods : The memory ameliorating effect of FKG was investigated using a passive avoidance test, the Y-maze test, and the Morris water maze test in mice. Drug-induced amnesia was induced by treating animals with scopolamine (1 mg/kg, i.p.). Results : FKG (2 or 4 mg/kg, p.o.) administration significantly reversed scopolamine-induced cognitive impairments in mice by the passive avoidance test and the Y-maze test (P<0.05), and also improved escape latency in the Morris water maze test at 2 or 4 mg/kg (P<0.05). Although FKG has little inhibitory activity for AChE (IC50 value; 1847 μg/ml) in an invitro study, phosphorylated extracellular signal-regulated kinase (pERK) was increased by the administration of FKG in hippocampus on immunohistochemistry. Conclusions : These results suggest that FKG may be a useful cognitive impairment treatment, and its beneficial effects are mediated, in part, via activation of ERK pathway.
Abstract
Objectives : The purpose of this study was to characterize the effect of the fraction of Korean mountain ginseng folium (FKG) on the learning and memory impairments induced by scopolamine. Methods : The memory ameliorating effect of FKG was investigated using a passive avoidance test, the Y-maze test, and the Morris water maze test in mice. Drug-induced amnesia was induced by treating animals with scopolamine (1 mg/kg, i.p.). Results : FKG (2 or 4 mg/kg, p.o.) administration significantly reversed scopolamine-induced cognitive impairments in mice by the passive avoidance test and the Y-maze test (P<0.05), and also improved escape latency in the Morris water maze test at 2 or 4 mg/kg (P<0.05). Although FKG has little inhibitory activity for AChE (IC50 value; 1847 μg/ml) in an invitro study, phosphorylated extracellular signal-regulated kinase (pERK) was increased by the administration of FKG in hippocampus on immunohistochemistry. Conclusions : These results suggest that FKG may be a useful cognitive impairment treatment, and its beneficial effects are mediated, in part, via activation of ERK pathway.
참고문헌 (42)
- 오세관, "신경전달물질과 뇌질환", pp.345~364 (2005), 신일상사
- Aisen PS, "Pharmacologic treatment options in Alzheimer's disease: optimizing disease management", J Am Acad Nurse Pract, Suppl, pp.5~7 (2005)
- Colombres M, "An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds", Curr Pharm Des, 10(25), pp.3121~3130 (2004)
- 박순권, "한약물의 치매치료에 관한 실험적 연구", 동의신경정신과학회지, 9(2), pp.19~35 (1998)
- 대한한방신경정신과학회, "한방신경정신의학", pp.125~ (2006), 집문당
- Park E, "Yukmijihwang-tang derivatives enhance cognitive processing in normal young adults: a double-blinded, placebo-controlled trial", Am J Chin Med, 33(10), pp.107~115 (2005)
- Tabuchi M, "Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease", J Ethnopharmacol, 122(1), pp.157~162 (2009)
- 김창민, "중약대사전", pp.3894~3895 (1997), 정담
- Kim TH, "Effects of tissue-cultured mountain ginseng(Panax ginseng CA Meyer) extract on male patients with erectile dysfunction", Asian J Androl, 11(3), pp.356~361 (2009)
- 배만종, "장뇌삼 엽차의 항산화활성 및 지질대사에 미치는 영향", 한국식생활문화학회지, 24(1), pp.77~83 (2009), 한국식생활문화학회
- 김성진, "山蔘, 長腦蔘, 人蔘의 抗癌效果에 대한 비교연구", 대한본초학회지, 19(2), pp.41~50 (2004), 대한본초학회
- Yoo BS, "Differences in Phenolic Compounds between Korean Ginseng and Mountain Ginseng", Korean Journal of Biotechnology and Bioengineering, 15(2), pp.120~124 (2000)
- Lee HJ, "Differences in Free Amino Acids between Korean Ginsengs and Mountain Ginsengs", Korean Journal of Biotechnology and Bioengineering, 15(3), pp.323~328 (2000)
- Ebert U, "Scopolamine model of dementia: electroencephalogram findings and cognitive performance", Eur J Clin Invest, 28(11), pp.944~949 (1998)
- Oh MH, "Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity", Phytomedicine, 11(6), pp.544~548 (2004)
- Lockhart BP, "Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which?", Exp Gerontol, 38(1), pp.119~128 (2003)
- Simard M, "Memory assessment in studies of cognition-enhancing drug sfor Alzheimer's disease", Drugs Aging, 14(3), pp.197~230 (1999)
- Cummings JL, "Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis", Neurobiol Aging, 21(6), pp.845~861 (2000)
- 조명재, "한국노인정신질환의 현황", 신경정신의학, 41(5), pp.760~761 (2002)
- David D, "Neurobiology of Alzheimer's Disease", pp.2~36 (2007), The United Kingdom:Oxford university press
- Evans DA, "Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported", JAMA, 262(18), pp.2551~2556 (1989)
- Bekinschtein P, "Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus", Neuron, 53(2), pp.261~277 (2007)
- McGaugh JL, "Memory--a century of consolidation", Science, 287(5451), pp.248~251 (2000)
- McGaugh JL, "The contribution of pharmacology to research on the mechanisms of memory formation", Trends Pharmacol Sci, 21(6), pp.208~210 (2000)
- Mizuno K, "Hippocampus-dependent memory formation: do memory type-specific mechanisms exist?", J Pharmacol Sci, 98(3), pp.191~197 (2005)
- Vianna MR, "Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task intherat", Learn Mem, 7(5), pp.333~340 (2000)
- Bozdagi O, "The neurotrophin -inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism", J Neurosci, 28(39), pp.9857~9869 (2008)
- Myhrer T, "Neurotransmitter systems involved in learning and memory in the rat: a meta -analysis based on studies of four behavioral tasks", Brain Res Rev, 41, pp.268~287 (2003)
- Blokland, A, "Acetylcholine: a neurotransmitter for learning and memory", Brain Res. Brain Res Rev, 21, pp.285~300 (1995)
- Nobili L, "Cholinergic modulation, visual function and Alzheimer's dementia", Vision Res, 37(24), pp.3559~3571 (1997)
- Giacobini E, "From molecular structure to Alzheimer therapy", Jpn J Pharmacol, 74(3), pp.225~241 (1997)
- Giacobini E, "Present and future of Alzheimer therapy", J Neural Transm Suppl, 59, pp.231~242 (2000)
- Bachurin SO, "Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease", Med Res Rev, 23(1), pp.48~88 (2003)
- 張介賓, "張氏景岳全書", pp.610~611 (1978), 翰成社
- 楊思澍, "中醫臨床大全", pp.224~816 (1991), 北京科學技術出版社
- 宋美令, "노인치매의 치료에 관한 한의학적 연구", 대전대학교 한의학연구소 논문집, 6(11), pp.37~75 (1997)
- 陳士澤, "國譯石室秘錄", pp.102~ (1984), 書苑堂
- 錢鏡湖, "辨證奇聞全書", pp.222~235 (1990), 甘地出版社
- 許曉蓉, "淺淡老年痴呆證的證治", 浙江中醫學院學報, 19(3), pp.2~ (1995)
- 李中梓, "醫宗必讀", pp.323~324 (1987), 上海科學技術出版社
- 한방약리학 교재편찬위원회, "한방약리학", pp.29~32 (2005), 신일상사
- Chi JF, "Treatment of Alzheimer disease: an evidence-based review", Zhong Xi Yi Jie He Xue Bao, 5(3), pp.247~254 (2007)
